UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Increasing CO₂ changes community composition of pico- and nano-sized protists and prokaryotes at a coastal Antarctic site

Marine ecology. Progress series (Halstenbek), 2016-07, Vol.554, p.51-69

2016

Volltextzugriff (PDF)

Increasing CO sub(2) changes community composition of pico- and nano-sized protists and prokaryotes at a coastal Antarctic site

Marine ecology. Progress series (Halstenbek), 2016-01, Vol.554, p.51-69

2016

Volltextzugriff (PDF)

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

Cancers, 2019-05, Vol.11 (5), p.674

2019

Volltextzugriff (PDF)

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Frontiers in immunology, 2019-05, Vol.10, p.1149-1149

2019

Volltextzugriff (PDF)

The integrin αvβ6: a novel target for CAR T-cell immunotherapy?

Biochemical Society transactions, 2016-04, Vol.44 (2), p.349

2016

Volltextzugriff (PDF)

CAR T-cell immunotherapy: The path from the by-road to the freeway?

Molecular oncology, 2015-12, Vol.9 (10), p.1994-2018

2015

Volltextzugriff (PDF)

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma

Oncoimmunology, 2017-12, Vol.6 (12), p.e1363137-e1363137

2017

Volltextzugriff (PDF)

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Frontiers in immunology, 2020-12, Vol.11, p.628776-628776

2020

Volltextzugriff (PDF)

Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy

Biology (Basel, Switzerland), 2024-03, Vol.13 (3), p.196

2024

Volltextzugriff (PDF)

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Molecular therapy, 2017-01, Vol.25 (1), p.259-273

2017

Volltextzugriff (PDF)

Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing

Advanced healthcare materials, 2015-06, Vol.4 (8), p.1180-1189

2015

Volltextzugriff (PDF)

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?

The Journal of immunology (1950), 2013-11, Vol.191 (9), p.4589-4598

2013

Volltextzugriff (PDF)

ErbB-targeted CAR T-cell immunotherapy of cancer

Immunotherapy, 2015-03, Vol.7 (3), p.229-241

2015

Volltextzugriff (PDF)

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer

Cancer Immunology, Immunotherapy, 2018-11, Vol.67 (11), p.1753-1765

2018

Volltextzugriff (PDF)

Generation and application of TGFβ-educated human Vγ9Vδ2 T cells

STAR protocols, 2022-06, Vol.3 (2), p.101319-101319, Article 101319

2022

Volltextzugriff (PDF)

Adoptive Immunotherapy of Epithelial Ovarian Cancer with V gamma 9V delta 2 T Cells, Potentiated by Liposomal Alendronic Acid

The Journal of immunology (1950), 2014-12, Vol.193 (11), p.5557-5566

2014

Volltextzugriff (PDF)

Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors

Cell reports. Medicine, 2021-12, Vol.2 (12), p.100457-100457, Article 100457

2021

Volltextzugriff (PDF)

Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid

The Journal of immunology (1950), 2014-12, Vol.193 (11), p.5557-5566

2014

Volltextzugriff (PDF)

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin

The Journal of immunology (1950), 2013-09, Vol.191 (5), p.2437-2445

2013

Volltextzugriff (PDF)

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Molecular therapy, 2017-10, Vol.25 (10), p.2427-2427

2017

Volltextzugriff (PDF)

Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation

STAR protocols, 2022-06, Vol.3 (2), p.101414-101414, Article 101414

2022

Volltextzugriff (PDF)

TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer

Cell reports. Medicine, 2021-12, Vol.2 (12), p.100473-100473, Article 100473

2021

Volltextzugriff (PDF)

A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC)

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.3046-3046

2018

Volltextzugriff (PDF)

Abstract CT118: T4 immunotherapy of head and neck squamous cell carcinoma using pan-ErbB targeted CAR T-cells

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.CT118-CT118

2017

Volltextzugriff (PDF)

Abstract B129: Chimeric antigen receptor T-cells targeting the αvβ6 integrin demonstrate potent antitumor activity in multiple solid tumors

Cancer immunology research, 2016-01, Vol.4 (1_Supplement), p.B129-B129

2016

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Increasing CO₂ changes community composition of pico- and nano-sized protists and prokaryotes at a coastal Antarctic site

Increasing CO sub(2) changes community composition of pico- and nano-sized protists and prokaryotes at a coastal Antarctic site

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

The integrin αvβ6: a novel target for CAR T-cell immunotherapy?

CAR T-cell immunotherapy: The path from the by-road to the freeway?

CAR T-cell immunotherapy of MET-expressing malignant mesothelioma

Corrigendum: CAR T Cells Targeting the Tumor MUC1 Glycoprotein Reduce Triple-Negative Breast Cancer Growth

Engineering a Dual Specificity γδ T-Cell Receptor for Cancer Immunotherapy

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Ovarian Cancer Immunotherapy Using PD-L1 siRNA Targeted Delivery from Folic Acid-Functionalized Polyethylenimine: Strategies to Enhance T Cell Killing

Preclinical in vivo modeling of cytokine release syndrome induced by ErbB-retargeted human T cells: identifying a window of therapeutic opportunity?

ErbB-targeted CAR T-cell immunotherapy of cancer

Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer

Generation and application of TGFβ-educated human Vγ9Vδ2 T cells

Adoptive Immunotherapy of Epithelial Ovarian Cancer with V gamma 9V delta 2 T Cells, Potentiated by Liposomal Alendronic Acid

Synergistic T cell signaling by 41BB and CD28 is optimally achieved by membrane proximal positioning within parallel chimeric antigen receptors

Adoptive immunotherapy of epithelial ovarian cancer with Vγ9Vδ2 T cells, potentiated by liposomal alendronic acid

Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with Carboplatin

Targeting of Aberrant αvβ6 Integrin Expression in Solid Tumors Using Chimeric Antigen Receptor-Engineered T Cells

Generation of human parallel chimeric antigen receptor (pCAR) T cells to achieve synergistic T cell co-stimulation

TGF-β1 potentiates Vγ9Vδ2 T cell adoptive immunotherapy of cancer

A phase I trial of T4 CAR T-cell immunotherapy in head and neck squamous cancer (HNSCC)

Abstract CT118: T4 immunotherapy of head and neck squamous cell carcinoma using pan-ErbB targeted CAR T-cells

Abstract B129: Chimeric antigen receptor T-cells targeting the αvβ6 integrin demonstrate potent antitumor activity in multiple solid tumors

Suchergebnisse filtern